RHPN1-AS1

Across TCGA pan-cancer cohorts, RHPN1-AS1 RNA differs between tumor and matched normal tissue in 16 of 18 cancer types tested, making tumor–normal expression one of RHPN1-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RHPN1-AS1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RHPN1-AS1 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

BLCA, COAD, and LUAD are the cancer types where RHPN1-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RHPN1-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	Female	All	+1.198	<.001	11	view →
COAD	All	III,IV	+1.196	<.001	11	view →
LUAD	Female	III,IV	+1.085	<.001	11	view →
LIHC	Male	All	+0.882	<.001	8	view →
KIRP	All	All	+0.459	.002	8	view →
THCA	All	All	−0.406	<.001	7	view →
BRCA	All	III,IV	+1.450	<.001	6	view →
LUSC	Female	All	+1.260	<.001	6	view →
UCEC	All	All	+1.236	<.001	6	view →
STAD	Male	II,III,IV	+1.092	<.001	6	view →
HNSC	All	All	+0.425	.002	6	view →
CHOL	All	All	+1.368	<.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 16 lineages.

RHPN1-AS1–BLCA

Open the BLCA breakdown →